Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
The cath labs of the future | Melatonin linked to heart risks | GLP-1 drugs & healthy choices | Key FDA approval not unanimous
Monday, November 10, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

CCTA will play an essential role in the cath labs of the future

Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview. 

READ MORE >
Carlos Collet, MD, PhD, director, cardiovascular imaging, physiology and translational therapeutics, Cardiovascular Research Foundation, explains how noninvasive coronary CT angiography (CCTA) assessments will play a major role to eliminate invasive diagnostic angiography and to pre-plan percutaneous coronary intervention (PCI) procedures.
Share on Twitter Share on Facebook Share on Linkedin

CCTA will play an essential role in the cath labs of the future

Share on Twitter Share on Facebook Share on Linkedin
Carlos Collet, MD, PhD, director, cardiovascular imaging, physiology and translational therapeutics, Cardiovascular Research Foundation, explains how noninvasive coronary CT angiography (CCTA) assessments will play a major role to eliminate invasive diagnostic angiography and to pre-plan percutaneous coronary intervention (PCI) procedures.
Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview. 
READ MORE >

Is long-term melatonin use safe? New study highlights heart risks

Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep. 

READ MORE >
sleep bed insomnia awake
Share on Twitter Share on Facebook Share on Linkedin

Is long-term melatonin use safe? New study highlights heart risks

Share on Twitter Share on Facebook Share on Linkedin
sleep bed insomnia awake
Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep. 
READ MORE >

GLP-1 drugs and healthy lifestyle choices work in tandem to protect the heart

The rise of these medications continues to be one of the biggest stories in healthcare.

READ MORE >
Wegovy and happy people walking
Share on Twitter Share on Facebook Share on Linkedin

GLP-1 drugs and healthy lifestyle choices work in tandem to protect the heart

Share on Twitter Share on Facebook Share on Linkedin
Wegovy and happy people walking
The rise of these medications continues to be one of the biggest stories in healthcare.
READ MORE >

Some reviewers opposed FDA's approval of new drug for life-threatening disease

When the FDA approved elamipretide for the treatment of Barth syndrome, not everyone agreed with the agency's decision. 

READ MORE >
pharmaceutical drug approval process
Share on Twitter Share on Facebook Share on Linkedin

Some reviewers opposed FDA's approval of new drug for life-threatening disease

Share on Twitter Share on Facebook Share on Linkedin
pharmaceutical drug approval process
When the FDA approved elamipretide for the treatment of Barth syndrome, not everyone agreed with the agency's decision. 
READ MORE >

Featured Articles

A significant risk in female heart patients: Paradoxical low-flow, low-gradient AS

Sponsored by Medtronic

Identifying the signs of severe aortic stenosis is typically a fairly straightforward process for cardiologists. In some cases, however, the patient’s symptoms present in a way that is outside of the norm. 

READ MORE >
heart data research doctor cardiologist AI
Share on Twitter Share on Facebook Share on Linkedin

A significant risk in female heart patients: Paradoxical low-flow, low-gradient AS

Sponsored by Medtronic

Share on Twitter Share on Facebook Share on Linkedin
heart data research doctor cardiologist AI
Identifying the signs of severe aortic stenosis is typically a fairly straightforward process for cardiologists. In some cases, however, the patient’s symptoms present in a way that is outside of the norm. 
READ MORE >

Insulin pumps recalled due to malfunction risk—users warned to update software

The new Class I recall covers nearly 18,000 insulin pumps distributed throughout the United States. While this is not a product removal, users are being urged to update their devices immediately. 

READ MORE >
Tandem Mobi Insulin Pump
Share on Twitter Share on Facebook Share on Linkedin

Insulin pumps recalled due to malfunction risk—users warned to update software

Share on Twitter Share on Facebook Share on Linkedin
Tandem Mobi Insulin Pump
The new Class I recall covers nearly 18,000 insulin pumps distributed throughout the United States. While this is not a product removal, users are being urged to update their devices immediately. 
READ MORE >

Heart Rhythm Advocates town hall to review key EP policies

Leaders from HRS and Heart Rhythm Advocates will take the stage to explore policy updates, advocacy goals for the future and much more.

READ MORE >
Heart Rhythm Society electrophysiology public policy advocacy through Heart Rhythm Advocates. through
Share on Twitter Share on Facebook Share on Linkedin

Heart Rhythm Advocates town hall to review key EP policies

Share on Twitter Share on Facebook Share on Linkedin
Heart Rhythm Society electrophysiology public policy advocacy through Heart Rhythm Advocates. through
Leaders from HRS and Heart Rhythm Advocates will take the stage to explore policy updates, advocacy goals for the future and much more.
READ MORE >

Transcaval access a safe, effective alternative during Impella implants

In some cases, researchers noted, cardiologists may need to rely on transcaval access during the treatment of a high-risk heart failure patient. 

READ MORE >
High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP), according to new findings published in the American Journal of Cardiology. Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock
Share on Twitter Share on Facebook Share on Linkedin

Transcaval access a safe, effective alternative during Impella implants

Share on Twitter Share on Facebook Share on Linkedin
High-risk percutaneous coronary intervention (PCI) with an Impella heart pump is associated with better outcomes, including a significantly higher survival rate, than high-risk PCI with an intra-aortic balloon pump (IABP), according to new findings published in the American Journal of Cardiology. Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock
In some cases, researchers noted, cardiologists may need to rely on transcaval access during the treatment of a high-risk heart failure patient. 
READ MORE >

Large-scale policy changes fail to boost heart failure outcomes—what else is needed?

A system-wide initiative in Sweden helped hospitals reduce readmission rates and shorten lengths of stay. When it came to heart failure patients specifically, however, the changes barely made an impact.

READ MORE >
Hospital staff walking through a medical facility, intentionally blurred to look artistic
Share on Twitter Share on Facebook Share on Linkedin

Large-scale policy changes fail to boost heart failure outcomes—what else is needed?

Share on Twitter Share on Facebook Share on Linkedin
Hospital staff walking through a medical facility, intentionally blurred to look artistic
A system-wide initiative in Sweden helped hospitals reduce readmission rates and shorten lengths of stay. When it came to heart failure patients specifically, however, the changes barely made an impact.
READ MORE >

In Case You Missed It

Medtronic launches FDA-cleared guidewire compatible with multiple TAVR systems

The guidewire was built specifically with Medtronic's own Evolut platform in mind. However, it is also compatible with all other commercially available TAVR systems.

READ MORE >
Medtronic Stedi Extra Support guidewire
Share on Twitter Share on Facebook Share on Linkedin

Medtronic launches FDA-cleared guidewire compatible with multiple TAVR systems

Share on Twitter Share on Facebook Share on Linkedin
Medtronic Stedi Extra Support guidewire
The guidewire was built specifically with Medtronic's own Evolut platform in mind. However, it is also compatible with all other commercially available TAVR systems.
READ MORE >

The push to get 3D echo into the congenital operating room

Nee Khoo, MBChB, director of the echocardiography lab at Canada's Stollery Children’s Hospital, explains the rapid adoption of pediatric 3D transesophageal echo.

READ MORE >
Dr. Nee Khoo, director of the echocardiography lab, Stollery Children’s Hospital, Edmonton, Canada, explains the rapidly growing adoption of pediatric 3D transesophageal echo (TEE) to not only preplan, but also guide and assess the results of congenital heart surgeries.
Share on Twitter Share on Facebook Share on Linkedin

The push to get 3D echo into the congenital operating room

Share on Twitter Share on Facebook Share on Linkedin
Dr. Nee Khoo, director of the echocardiography lab, Stollery Children’s Hospital, Edmonton, Canada, explains the rapidly growing adoption of pediatric 3D transesophageal echo (TEE) to not only preplan, but also guide and assess the results of congenital heart surgeries.
Nee Khoo, MBChB, director of the echocardiography lab at Canada's Stollery Children’s Hospital, explains the rapid adoption of pediatric 3D transesophageal echo.
READ MORE >

A promising SELUTION: Sirolimus-eluting balloon from Cordis makes impression at TCT 2025

The SELUTION SLR Drug-Eluting Balloon was the topic of two different late-breaking clinical trials at TCT 2025. Both studies found that the device was noninferior to traditional treatments after one year. Long-term data are still needed. 

READ MORE >
Christian M. Spaulding, MD, PhD, at TCT 2025
Share on Twitter Share on Facebook Share on Linkedin

A promising SELUTION: Sirolimus-eluting balloon from Cordis makes impression at TCT 2025

Share on Twitter Share on Facebook Share on Linkedin
Christian M. Spaulding, MD, PhD, at TCT 2025
The SELUTION SLR Drug-Eluting Balloon was the topic of two different late-breaking clinical trials at TCT 2025. Both studies found that the device was noninferior to traditional treatments after one year. Long-term data are still needed. 
READ MORE >

In Other News

Healthcare AI today: Billions for AI-based biotech, fast ROI or else, AI for imprisoned patients, more

The Zuckerbergs have many billions to give away. They want to shower a lot of it on researchers using AI to cure diseases.

READ MORE >
llama meta zuckerberg
Share on Twitter Share on Facebook Share on Linkedin

Healthcare AI today: Billions for AI-based biotech, fast ROI or else, AI for imprisoned patients, more

Share on Twitter Share on Facebook Share on Linkedin
llama meta zuckerberg
The Zuckerbergs have many billions to give away. They want to shower a lot of it on researchers using AI to cure diseases.
READ MORE >

Ohio AG investigating business practices of nonprofit safety net hospital

Authorities said in a court filing that they received a complaint about Northeast Ohio Neighborhood Health Services’ business practices. The health system owes more than $12 million to creditors, and investigators are asking to see its financial records.

READ MORE >
jury court verdict juror lawsuit trial
Share on Twitter Share on Facebook Share on Linkedin

Ohio AG investigating business practices of nonprofit safety net hospital

Share on Twitter Share on Facebook Share on Linkedin
jury court verdict juror lawsuit trial
Authorities said in a court filing that they received a complaint about Northeast Ohio Neighborhood Health Services’ business practices. The health system owes more than $12 million to creditors, and investigators are asking to see its financial records.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup